Tranexamic EP Impurity A (Free Base)

Also known as Tranexamic BP Impurity A or Tranexamic Related Compound A or Tranexamic Acid Dimer (Free Base) is one of impurity present in Tranexamic, tranexamic acid is a synthetic derivative of lysine that act as antifibrinolytic effects by blocking lysine binding sites on plasminogen molecules. which shows inhibition of plasminogen activation results in stabilization of the preformed fibrin, also it reduces bleeding and improves clinical outcomes in the face of many different hemostatic challenges without a clear increase in thrombotic risk. Tranexamic acts on postpartum hemorrhage, trauma-associated hemorrhage, and surgical bleeding.

Additional information on Tranexamic EP Impurity A (Free Base)

Catalogue No.

VE009293

CAS No.

N/A

Molecular Formula

C16H27NO4

Molecular Weight

297.39 g/mol

Parent drug

Tranexamic

IUPAC Name

trans, trans-4, 4?-(Iminodimethylene)di(cyclohexanecarboxylic)acid

Synonyms

Tranexamic BP Impurity A / Tranexamic Related Compound A / Tranexamic Acid Dimer (Free Base)

References

Cai, J., Ribkoff, J., Olson, S., Raghunathan, V., Al‐Samkari, H., DeLoughery, T. G., & Shatzel, J. J. (2019). The many roles of tranexamic acid: An overview of the clinical indications for TXA in medical and surgical patients. European Journal of Haematology, 104(2), 79–87. https://doi.org/10.1111/ejh.13348

Status

In-stock

[rfq_list]

Login first to add product to RFQ List

Request a quote

Tranexamic EP Impurity A (Free Base)

Tranexamic EP Impurity A (Free Base)
Catalogue No.

VE009293

CAS No.

N/A

Molecular Formula

C16H27NO4

Molecular Weight

297.39 g/mol

Parent drug

Tranexamic

IUPAC Name

trans, trans-4, 4?-(Iminodimethylene)di(cyclohexanecarboxylic)acid

Synonyms

Tranexamic BP Impurity A / Tranexamic Related Compound A / Tranexamic Acid Dimer (Free Base)

References

Cai, J., Ribkoff, J., Olson, S., Raghunathan, V., Al‐Samkari, H., DeLoughery, T. G., & Shatzel, J. J. (2019). The many roles of tranexamic acid: An overview of the clinical indications for TXA in medical and surgical patients. European Journal of Haematology, 104(2), 79–87. https://doi.org/10.1111/ejh.13348

Status

In-stock

ListName

Tranexamic EP Impurity A (Free Base)

Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url
 
Hidden